MT-II is associated with reported cases of benign nevi modification (darkening) and, more rarely, with dermatological concerns (warranting dermato-oncological surveillance in at-risk subjects)
Ethics statement The animal study was reviewed and approved, and all experimental work was executed in accordance with the guiding principles of the Institute of Laboratory Animal Resources, Commission on Life Sciences University, National Research Council (1996), accepted through the Ethical Committee of Riphah Institute of Pharmaceutical Sciences (Ref
[Pathogenetic mechanisms for the development of hematological disorders in induced fatty liver disease in Wistar rats and assessment of the regulatory effects of carnosine and -lipoic acid].[Vopr Pitan
This combination is typically used as a dietary supplement and should be taken according to the prescribed dosage
Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan-zinc-insulin complexes incorporated in thermosensitive copolymer
As with any medication, it's important to discuss with a healthcare provider whether a GLP-1 receptor agonist is a suitable option for managing diabetes
